The Cell Cycle
The Cell Cycle
The cell cycle is controlled by numerous mechanisms ensuring correct cell division. Cell division consists of two consecutive processes, mainly characterized by DNA replication (S phase), proceeding after G1 interphase; and segregation of replicated chromosomes into two separate cells (M phase), following G2 phase. Cyclin E is upregulated during G1/S progression whereas Cyclin A and Cyclin B are expressed highly during G2/M progression. Phosphorylated Histone H3 is a distinct marker for Mitosis and often used in determining cells undergoing M-phase in a proliferating populations. arigo’s Cell Cycle Marker Panel provides a useful tool as markers for cells undergoing different phases in cell cycle. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Retinoblastoma protein (Rb), encoded by the RB1 gene, is a critical regulator of cell cycle progression and has an important role in numerous aspects of biology, including DNA damage response, apoptosis, senescence and differentiation. Rb is an important regulator of the cell cycle that acts predominantly by binding to and inhibiting the gene transactivation by E2F transcription factors, which would otherwise induce the expression of genes that enhance cell cycle progression. The biological function of Rb is critically regulated by protein phosphorylation. Hypophosphorylated Rb interacts with E2F, thereby acting as the biologically active form of Rb. Conversely, hyperphosphorylated Rb is unable to bind E2F proteins, thereby allowing E2F to promote cell cycle progression. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DNA damage signaling cascades are complex that require the actions of various proteins. When single or double DNA strain break occurs (SSB or DSB), MRN contributes to the recruitment and activation of the apical DDR kinase ATM, while RPA recruits the ATR kinase via its partner protein, ATRIP. Activated ATM/ATR will then phosphorylate a few target proteins, including p53, Histone H2A, and Chk1/Chk2, triggering downstream signaling pathway to halt cell cycle progression. This antibody panel investigates the response of DNA damage. Activation of ATM by autophosphorylation on Ser1981 occurs in response to DNA double strand breaks. Chk1 and Chk2, downstream protein kinases of ATM/ATR, play important role in DNA damage checkpoint control, embryonic development and tumor suppression. Chk1 is phosphorylated at Ser280 and Ser296 upon DNA damage. The amino-terminal domain of Chk2 contains a series of seven serine or threonine residues, where Thr68 and Ser516 in this region became phosphorylated by ATM/ATR. Downstream target, gamma-H2AX, is phosphorylated at serine139 in responsive to DNA DSB. Phosphorylation of another downstream target p53 on serine 15 and 37 residues inhibit its interaction with Mdm2. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARG51633 Rb pSer780 antibody |
ARG63080 p21 antibody [WA-1] (Human primary fibroblasts) |
ARG54677 p19 INK4d antibody |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARG51386 CDK6 antibody |
ARG51834 MDM2 pSer166 antibody (Methanol-fixed HeLa cells) |
ARG52923 Cyclin D1 antibody [SP4] (Human Mantle Cell Lymphoma) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|